Carboplatin/nivolumab/pembrolizumabParaneoplastic neurologic syndromes presenting as encephalitis and sensory neuronopathy: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1761卷 / 1期

关键词：

D O I：

10.1007/s40278-019-64473-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[21] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1751 (1) : 301 - 301
[22] Nivolumab/temozolomideLack of efficacy: 3 case reports
Reactions Weekly, 2023, 1986 (1) : 338 - 338
[23] Ipilimumab/nivolumab/pembrolizumabGastroparesis: 3 case reports
Reactions Weekly, 2021, 1871 (1) : 216 - 216
[24] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1858 (1) : 313 - 313
[25] Nivolumab/pembrolizumabLack of efficacy: 3 case reports
Reactions Weekly, 2023, 1947 (1) : 323 - 323
[26] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2017, 1649 (1) : 194 - 194
[27] Ipilimumab/nivolumab/pembrolizumabSarcoidosis: 3 case reports
Reactions Weekly, 2017, 1678 (1) : 109 - 109
[28] Nivolumab/rituximabLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1902 (1) : 348 - 348
[29] Nivolumab/pembrolizumabPulmonary toxicity: 3 case reports
Reactions Weekly, 2021, 1853 (1) : 367 - 367
[30] Cemiplimab/nivolumab/pembrolizumabMyocarditis : 3 case reports
Reactions Weekly, 2020, 1829 (1) : 113 - 113

← 1 2 3 4 5 →